Table of Contents
CBD Benefits For Neurological Disorders
This study summary provides fact-based answers about CBD benefits for brain aging diseases.
- learn exactly how CBD protects the brain from neurodegenerative disorders
- discover the optimal CBD dosage tested and possible adverse effects
- find out how this nonintoxicating compound may protect the brain from some effects of aging
If you don’t find an answer in this guide to a question you have, leave us a comment below. We’ll search the published studies to see if an answer exists and get back to you.
Let’s get started.
2019 Study: There is evidence for therapeutic effects of CBD on multiple neurological disorders. #cbd #dementia #alzheimers #epilepsy tell a friend
Published December 12, 2019
Study Results
There is evidence for therapeutic effects of CBD on multiple neurological disorders including:
- Alzheimer’s
- Parkinson disease
- Huntington disease
- multiple sclerosis
- stroke
- epilepsy
- amyotrophic lateral sclerosis
- traumatic brain injury
- glioblastoma (1)
CBD is one of the major ways that the endocannabinoid system (a regulatory system in your body) relays signals to maintain the good functioning of critical health systems. (2)
Summary
- This research is a review of the literature and a discussion of reasons for cannabinoid success and failure in treating neurological disorders.
- This CBD research explains why cannabinoids have varying effects on neurological disorders and propose that the endocannabinoidome (the larger endocannabinoid signaling system) is the reason for the imprecise effects of treating patients with cannabinoids. (3)
Interested to learn exactly how CBD relieves pain? Guide to CBD benefits for pain and inflammation relief.
Video: CBD For Parkinson’s Disease
Download The CBD Research
Keywords: neurological disorder, Parkinson’s disease, Alzheimer’s disease, Huntington disease, multiple sclerosis, amyotrophic lateral sclerosis, traumatic brain injury, stroke, epilepsy, glioblastoma.
References
Cristino L, Bisogno T, Di Marzo V. Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat Rev Neurol. 2020;16(1):9–29. doi:10.1038/s41582-019-0284-z
Study Authors
Institute of Biomolecular Chemistry, Consiglio Nazionale delle Ricerche
Institute of Translational Pharmacology, Consiglio Nazionale delle Ricerche
Institute of Biomolecular Chemistry, Consiglio Nazionale delle Ricerche
Heart and Lung Research Institute of Université Laval, Québec City, Québec
Institute for Nutrition and Functional Foods, Université Laval, Québec City